Etiology and antibiotic susceptibility patterns of community-acquired urinary tract Infections in a Kuwait Hospital

Medical Principles and Practice

Volumn 13, Issue 6, 2004, Pages 334-339

  Dimitrov, T S ^a   Udo, E E ^b   Awni, F ^a   Emara, M ^a   Passadilla, R ^a  

^a Infectious Diseases Hospital Kuwait   (Kuwait)

^b KUWAIT UNIVERSITY   (Kuwait)

Author keywords

Antibiotic sensitivity patterns; Community acquired infection; Extended spectrum lactamase; Urinary tract infections

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; BETA LACTAMASE; CEFALOTIN; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN; CIPROFLOXACIN; CLAVULANIC ACID; COTRIMOXAZOLE; GENTAMICIN; GLYCOPEPTIDE; IMIPENEM; NALIDIXIC ACID; OXACILLIN; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; TEICOPLANIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; BACTERIURIA; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; DIFFUSION; ENTEROBACTERIACEAE; ESCHERICHIA COLI; HOSPITAL; KLEBSIELLA; KUWAIT; MEDICAL RECORD; MULTIDRUG RESISTANCE; NONHUMAN; PATIENT INFORMATION; PREVALENCE; STREPTOCOCCUS AGALACTIAE; URINALYSIS; URINARY TRACT INFECTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CHILD; COMMUNITY-ACQUIRED INFECTIONS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; KUWAIT; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; URINARY TRACT INFECTIONS; URINE;

EID: 5644293047     PISSN: 10117571     EISSN: None     Source Type: Journal    
DOI: 10.1159/000080470     Document Type: Article

References (26)

1. Kunin CM: Urinary tract infections in females. Clin Infect Dis 1994; 18: 1-12.
2. Kriger JN, Kaiser DL, Wenzel RP: Nosocomial urinary tract infections: Secular trends, treatment and economics in a university hospital. J Urol 1983; 130: 102-106.
3. Haley RW, Hooton TM, Culver DH, Stanley RC, Emori TG, Hardison CD: Nosocomial infections in US hospitals 1975-1976: Estimated frequency by selected characteristics of patients. Am J Med 1981; 70: 947-959.
4. Barnett BJ, Stephens DS: Urinary tract infection an overview. Am J Med Sci 1997; 4: 245-249.
5. Sirot DL, Goldstein FW, Soussy CJ, Courtien AL: Resistance to cefotaxime and seven other beta-lactams in members of the family Enterobacteriaceae: A 3-year survey in France. Antimicrob Agents Chemother 1992; 36: 1677-1681.
6. Goldstein FW, Pean Y, Rosato A, Genter J, Gutmann L: Characterization of ceftriaxoneresistant Enterobacteriaceae: A multicenter study in 26 French hospitals. J Antimicrob Chemother 1993; 32: 595-603.
7. Jones RN, Kugler KC. Pfaller MA, Winokur PL: Characteristic of pathogens causing urinary tract infections in hospitals in North America: Results from THE SENTRY antimicrobial surveillance program, 1997. Diagn Microbial Infect Dis 1999; 35: 55-63.
8. Weber Ph, Plaisance JJ, Nancy C: Epidemiologie comparee de la resistance aux fluoroquinolones chez lez Enterobacteriaceae et Pseudomonas aeruginosa en medicine de ville. Presse Méd 1995; 24: 979-982.
9. Weber G, Reisenberg K, Schlaeffer F, Peled N, Borer A, Yagupsky P: Changing trends in frequency and antimicrobial resistance of urinary pathogens in outpatient clinics and a hospital in southern Israel, 1991-1995. Eur J Clin Microbiol Infect Dis 1997; 16: 834-938.
10. Goldstein FW: Antibiotic susceptibility of bacterial strains isolated from patients with community-acquired urinary tract infections in France. Eur J Clin Microbiol Infect Dis 2000;19: 112-117.
11. Neu HC: Urinary tract infections. Am J Med 1992; 92(suppl 4a):63-70.
12. Schaeffer AJ: Urinary tract infections in elderly. Eur Urol 1991; 19(suppl):2-6.
13. Claridge JE, Pezzlo MT, Vosti KI: Cumitech 2A Laboratory Diagnosis of Urinary Infections. Weissfeld AS (coordinating ed). Washington, American Society for Microbiology, 1987.
14. Kass EH: Bacteriuria and the diagnosis of infections of the urinary tract. Arch Intern Med 1957; 100: 709-714.
15. Baron EJU, Peterson IR, Finegold SM: Bailey and Scotts Diagnostic Microbiology, ed 9. St Louis, Mosby, 1994 , pp 249-257.
16. National Committee for Clinical Laboratory Standards: Methods for Disk Susceptibility Tests for Bacteria That Grow Aerobically, ed 7. NCCLS Document M2-A7. Wayne, National Committee for Clinical Laboratory Standards, 2000.
17. Cormican MG, Marshall SA, Jones RN: Detection of extended-spectrum beta-lactamases (ESBL) producing strains by the E-test ESBL screen. J Clin Microbiol 1996; 34: 1880-1884.
18. Livermore DM, Yuan M: Antibiotic resistance and production of extended spectrum beta-lactamase amongst Klebsiella spp. from intensive care units in Europe. J Antimicrob Chemother 1996; 38: 409-424.
19. Livermore DM, Brown DF: Detection of betalactamase-mediated resistance. J Antimicrob Chemother 2001; 48(suppl 1):59-64.
20. Winstanley TG, Limb DL, Eggington R, Hancock F: A 10 years survey of the antimicrobial susceptibility of urinary tract isolates in the UK: The Microbe Base Project. J Antimicrob Chemother 1997; 40: 591-594.
21. Philippon A, Arlet G, Lagrange PH: Escherichia coli : Fréquence de résistance et évolution à divers antibiotiques urinaires dont la fosfomycine en milieu hospitalier. Méd Mal Infect 1996; 26: 539-541.
22. De Mouy D, Lepargneur JP, Auriol JC: Evolution des fréquences d'isolement et de la résistance des souches d' E. coli isolats d'infections urinaires en pratique de ville de 1986 à 1993. Méd Mal Infect 1994; 24: 539-542.
23. Hovelius B, Mardh PA: Staphylococcus saprophyticus as a common cause of urinary tract infections. Rev Infect Dis 1984; 6: 328-337.
24. Latham RH, Running K, Stamm WE: Urinary tract infections in young adult women caused by Staphylococcus saprophyticus . JAMA 1983;250: 3063-3066.
25. Pead L, Maskell R, Morris J: Staphylococcus saprophyticus as a urinary pathogen: A six year prospective survey. Br Med J 1985; 291: 1157-1159.
26. Sobel JD, Kaye D: Host factors in the pathogenesis of urinary tract infections. Am J Med 1984; 76(suppl 5A):122-130.